Eye Testing Equipment Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Eye Testing 
Equipment Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Accord ing  to  t he  la t es t  r epor t  by  IMARC Group,  t i t l ed  "Eye  Test ing  Equ i pment  
Market :  G l oba l  Indust ry  T rends ,  Share ,  S ize ,  Growth ,  O pportun i ty  and  
Forecast  2024-2032 ,"  t he  g loba l  eye  t es t i ng  equ ipment  marke t  s i ze  reached  US$  
3 . 2  B i l l i on  in  2023 .
Report Eye  tes t ing  equ ipment  re fe rs  to  med ica l  t oo l s  used  to  examine  and  de t ec t  de fec t s  
o r  abnorma l i t i es  in  t he  i n te rna l  s t r uc tu re  o f  t he  eye  or  t he  re t i na .  Op tomet r i s t s  
and  oph tha lmo log is t s  use  t hese  too l s  t o  per fo rm  numerous  eye  tes t s .  
Highlight and Foc ime te rs ,  b iomet ers ,  s l i t  l amps ,  au t o re f rac to rs ,  op t i ca l  coherence tomography  
(OCT)  scanners  and  f undus  cameras  a re  some o f  t he  mos t  used eye  tes t ing  
Description equ ipmen t  ava i lab le  in  t he  marke t .  I n  recen t  yea rs ,  eye  tes t ing  equ ipment  has  
ga ined  t r ac t ion  due  to  i t s  w idesp read employment  in  hosp i t a l s ,  academic  
ins t i t u t i ons  and  d iagnos t i c  c l i n i cs  to  examine  and d iagnose ca t a rac t ,  g laucoma,  
and  o ther  eye - re la t ed  d isorders .
Request  fo r  a  PDF  sample  o f  th i s  repor t :  
ht tps : / / www. imarcgroup .com/eye- tes t ing -equ ipm en t -marke t / reques t samp le
Report Description
G l ob a l  Ey e  Te s t i ng  Eq u i pm ent  M ark e t  T rend s :
O ne  o f  t he  p r im ar y  f ac t o r s  d r i v i ng  t h e  m a r ke t  i s  t he  r i s i ng  i nc id ence s  o f  eye - r e la t ed  d i so r de r s  due  t o  r ap id  d ig i t a l i z a t i on .  
Add i t io na l l y ,  t he  i nc r eas ing  g e r i a t r i c  popu la t i on  i s  c r ea t i n g  a  pos i t i ve  m ar ke t  ou t l ook .  O t he r  t ha n  t h i s ,  t he  i n t eg r a t i o n  o f  
eye  t es t i n g  e qu ipm en t  w i t h  l ensom et e r s ,  oph t ha lm o scop es ,  a nd  c om p u t e r iz ed  v i sua l  acu i t y  sys t em s  t o  ach ieve  be t t e r  
accu r acy  an d  p r ec i s ion  i s  po s i t i ve l y  i n f l uen c ing  t he  m a r ke t  g r o w t h .  Be s ides  t h i s ,  O CT d ev i ce s  a r e  heav i l y  u t i l i zed  f o r  
exam in ing  t he  d i s t i nc t i ve  l aye r s  o f  t he  r e t i n a  and  p r ov id ing  enha nced  ca r e  t o  i n d i v id ua l s  s u f f e r i ng  f r om  g lauc om a.  
I n  l i ne  w i t h  t h i s ,  t he  es ca la t in g  us age  o f  con t ac t  l enses  a nd  su r g i ca l  oph t ha lm ic  dev ic es  du r i ng  r e f r ac t i v e  e r r o r  co r r ec t i o n  
su r g e r y  i s  s t r eng t hen in g  t h e  m ar ke t  g r ow t h .  Fu r t he r m or e ,  t h e  g r ow ing  p r e va len ce  o f  n igh t  b l i nd ness ,  exce ss i ve  eyes t r a in ,  
co lo r b l i ndne ss ,  and  l azy  eye  d ue  t o  l onge r  du r a t i ons  o f  sc r een  t im e  i s  p r op e l l i ng  t h e  m ar ke t  g r ow t h .  O t he r  g r ow t h -
i nduc i ng  f ac t o r s  i n c lude  t he  im p lem e n t a t i on  o f  va r i ous  i n i t i a t i ves  t o  e duca t e  t h e  m asse s  ab ou t  v i s i on  hea l t h  a nd  t he  
r i s i ng  hea l t hca r e  exp end i t u r e  c apac i t i es .
Look i ng  f o rw ard ,  I M ARC  G roup  ex pec t s  t he  m ark e t  v a l ue  t o  reach  US $  5 . 2  B i l l i o n  by  2032 ,  ex pand i ng  a t  a  CA G R o f  
5 . 4%  dur i ng  t he  f o rec as t  p er i od  ( 2 02 4 - 20 32 ) .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / e ye - t e s t i ng - equ i pm en t - m arke t
Breakup by Device:
• Sl i t  Lamp
• Biometer
• Perimeter
• Tonometer
• Optical  Coherence Tomography (OCT)
• Fundus Camera
Report 
• Autorefractor and Keratometer
Segmentation • Others
Breakup by Application:
• General  Examination
• Glaucoma
• Cataract
• Others
Breakup by End User:
• Hospitals
• Eye Cl inics
• Optometry Academic Insti tutes
Breakup by Region:
Report • North America
Segmentation • Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Alcon Inc.  (Novart is AG)
• bon Optic
• Canon Medical  Systems USA (Canon Inc.)
Competitive • Carl  Zeiss AG (Carl-Zeiss-Stiftung)
• Essi lor International  (Essi lorLuxottica)
Landscape 
• HEINE Optotechnik GmbH & Co. KG
with Key • Luneau Technology Group
Players • Metal l  Zug AG
• NIDEK CO. LTD.
• Topcon Corporat ion.
How has the global eye testing equipment market performed 
so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the 
global market?
Key What is the impact of each driver, restraint, and opportunity 
on the global market?
Questions 
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive market?
What is the breakup of the market based on the device?
Which is the most attractive device in the market?
What is the breakup of the market based on the application?
Which is the most attractive application in the market?
Key 
What is the breakup of the market based on the end user?
Questions 
Answered in Which is the most attractive end user in the market?
the Report
What is the competitive structure of the market?
Who are the key players/companies in the global eye testing 
equipment market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  E y e  T e s t i n g  E q u i p m e n t  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  D e v i c e
    6 . 1     S l i t  L a m p
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     B i o m e t e r
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     P e r i m e t e r
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     T o n o m e t e r
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     O p t i c a l  C o h e r e n c e  T o m o g r a p h y  ( O C T )
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
    6 . 6     F u n d u s  C a m e r a
        6 . 6 . 1  M a r k e t  T r e n d s
        6 . 6 . 2  M a r k e t  F o r e c a s t
    6 . 7     A u t o r e f r a c t o r  a n d  K e r a t o m e t e r
        6 . 7 . 1  M a r k e t  T r e n d s
Table of         6 . 7 . 2  M a r k e t  F o r e c a s t
    6 . 8     O t h e r s
        6 . 8 . 1  M a r k e t  T r e n d s
Contents         6 . 8 . 2  M a r k e t  F o r e c a s t7    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    7 . 1     G e n e r a l  E x a m i n a t i o n
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     G l a u c o m a
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     C a t a r a c t
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     O t h e r s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /e ye - te s t i ng -eq u ip men t -m a rke t / t
o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: